Takeda is nearing the final stages of a joint venture with PRA Health Sciences, the product of an expansion of their clinical development partnership in Japan…

Embattled biotech Karyopharm is looking to move past its recent trial setbacks, penning an expansion to its original 2014 partnership on machine-learning tech…

Drug discovery firm Nimbus Therapeutics has reached a multiyear partnership with Charles River Laboratories.

A bipartisan bill that plans to allow a tax credit for expenses of contracted research—often done by CROs—has been introduced in the House of Representatives.

The European Medicines Agency wants to suspend around 300 marketed generic meds and applications due to its concerns.

Sciex, an expert in life science analytical technologies, joined hands with Australia’s Children’s Medical Research Institute to open a cancer proteome center.

Last year, Cardiff, U.K.-based Verona secured £44.7 million ($65.6 million) from big-name investors on both sides of the Atlantic for work on its PDE3/PDE4…

Chinese CRO Newsummit Biopharma has received a license to a hepatitis C antibody from MRC Technology, a medical research charity.

Charles River Laboratories has sealed the extension of a previous six-year early drug discovery contract in the field of respiratory disease with Chiesi…

R&D